Laurel Wealth Advisors LLC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 134 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2019. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
Laurel Wealth Advisors LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q4 2021$8,000
+33.3%
1500.0%0.00%
+100.0%
Q3 2021$6,0000.0%1500.0%0.00%0.0%
Q2 2021$6,000
+20.0%
1500.0%0.00%0.0%
Q1 2021$5,0000.0%1500.0%0.00%0.0%
Q4 2020$5,000
+25.0%
1500.0%0.00%0.0%
Q3 2020$4,0000.0%1500.0%0.00%0.0%
Q2 2020$4,000
+100.0%
1500.0%0.00%0.0%
Q1 2020$2,000
-60.0%
1500.0%0.00%
-50.0%
Q4 2019$5,000
+400.0%
1500.0%0.00%
Q3 2019$1,000
-50.0%
1500.0%0.00%
-100.0%
Q2 2019$2,0000.0%1500.0%0.00%0.0%
Q1 2019$2,0000.0%1500.0%0.00%0.0%
Q4 2018$2,0001500.00%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2019
NameSharesValueWeighting ↓
Sarissa Capital Management LP 675,000$26,203,0007.44%
EcoR1 Capital, LLC 244,950$9,509,0003.75%
Redmile Group, LLC 971,565$37,716,0003.60%
Ghost Tree Capital, LLC 120,000$4,658,0001.34%
SENZAR ASSET MANAGEMENT, LLC 144,624$5,614,304,0001.22%
GREAT POINT PARTNERS LLC 100,000$3,882,0001.11%
BB BIOTECH AG 700,000$27,174,0001.07%
Rhenman & Partners Asset Management AB 115,000$4,464,0000.79%
Lisanti Capital Growth, LLC 12,260$476,0000.72%
Rock Springs Capital Management LP 190,000$7,376,0000.55%
View complete list of INTRA CELLULAR THERAPIES INC shareholders